4//SEC Filing
Baumal Caroline 4
Accession 0001127602-24-000962
CIK 0001492422other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:14 PM ET
Size
4.5 KB
Accession
0001127602-24-000962
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-04$60.05/sh−2,751$165,207→ 32,931.37 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001961100
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:14 PM ET
- Size
- 4.5 KB